SOLID TUMOR, ADULT
Clinical trials for SOLID TUMOR, ADULT explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR, ADULT trials appear
Sign up with your email to follow new studies for SOLID TUMOR, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug DT-9081 trial halted early
Disease control TerminatedThis early-phase study tested a new drug called DT-9081 in 29 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited.
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Domain Therapeutics SA • Aim: Disease control
Last updated May 26, 2026 10:00 UTC
-
Experimental virus combo targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase study tested a new treatment called onCARlytics (CF33-CD19) given alone or with another drug (blinatumomab) in adults with advanced solid tumors that had not responded to prior therapies. The main goal was to check safety and find the best dose. The study was ter…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
New cancer pill tested in early trial, but study halted
Disease control TerminatedThis early-phase study tested an experimental oral drug called AUR105 in 17 adults with advanced solid tumors or lymphomas that had come back after prior treatment. The main goals were to check safety, how the drug moves through the body, and find the right dose. The study was te…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 26, 2026 09:55 UTC
-
Early-Stage cancer drug trial halted after only 3 patients
Disease control TerminatedThis early-phase study tested a new drug called AXN-2510 in 3 adults with advanced solid tumors that had stopped responding to other treatments. The main goals were to find safe dosing and understand side effects. The trial was terminated early, so results are limited.
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Axion Bio, Inc • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
Experimental cancer pill tested in 23 patients, study halted early
Disease control TerminatedThis early-stage study tested an experimental oral drug called NKT3447 in 23 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
New cancer drug candidate BGB-24714 enters early human testing
Disease control TerminatedThis early-stage study tested a new drug called BGB-24714 in 157 adults with advanced solid tumors that had spread or could not be removed by surgery. The main goal was to check the drug's safety and find the best dose when used alone or with chemotherapy or radiation. The study …
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 26, 2026 09:50 UTC
-
New cancer pill shows promise in early trial, but study halted
Disease control TerminatedThis early-phase study tested an experimental oral drug called IK-595 in 75 adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have specific RAS or RAF gene mutations and no standard treatment options left. The goal was to check the drug's safety…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Experimental virus therapy for advanced cancers shows early safety data
Disease control TerminatedThis early-stage study tested an experimental virus therapy called VAXINIA (CF33-hNIS) in 66 adults with advanced solid tumors that had spread. The virus was given either directly into tumors or through a vein, alone or with the immunotherapy drug pembrolizumab. The main goal was…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New cancer drug GEN2 tested in patients – study halted early
Disease control TerminatedThis early-phase study tested a new drug called GEN2 in 37 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to find a safe dose and check for side effects. The study was terminated early, so results are limited.
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: GenVivo, Inc. • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-stage study tested a new drug called AUR103 Calcium in 27 adults with advanced cancers that had stopped responding to standard treatments. The goal was to find a safe dose and see how the drug worked in the body. The trial was terminated early, so no final results are …
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 14, 2026 12:06 UTC